Home/Filings/4/0000902664-21-003255
4//SEC Filing

Yi Qingqing 4

Accession 0000902664-21-003255

CIK 0001651308other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 12:26 PM ET

Size

7.7 KB

Accession

0000902664-21-003255

Insider Transaction Report

Form 4
Period: 2021-06-16
Yi Qingqing
Director
Transactions
  • Award

    Share Option (Right to Buy)

    2021-06-16+17,49817,498 total
    Exercise: $26.53Exp: 2031-06-15Ordinary Shares (17,498 underlying)
  • Award

    Ordinary Shares

    2021-06-16+7,8007,800 total
Footnotes (3)
  • [F1]Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.
  • [F2]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares.
  • [F3]These securities vest over a four-year period as follows: 25% on the first anniversary of June 16, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested shares are subject to accelerated vesting upon change of control or certain termination events.

Documents

1 file

Issuer

BeiGene, Ltd.

CIK 0001651308

Entity typeother

Related Parties

1
  • filerCIK 0001662556

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 12:26 PM ET
Size
7.7 KB